Skip to content
OpenCapital
Get started

IN8bio INAB Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

EPS-$0.26Miss by $0.08
Revenue estimate$16.0M
EPS estimate-$0.18

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.34

Versus estimates

Diluted EPS

Q1 2026-$0.26Beat by $0.33
Q4 2025-$0.26Miss by $0.08
Q3 2025-$0.85Beat by $0.35Q2 2025-$1.24Beat by $0.26Q1 2025-$2.10Miss by $0.30Q4 2024-$0.04Beat by $0.03

Ask the moment IN8bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did IN8bio report Q4 2025 earnings?
IN8bio (INAB) reported Q4 2025 earnings on March 12, 2026 before market open.
What were IN8bio's Q4 2025 revenue and EPS?
IN8bio reported eps of $-0.26 for Q4 2025.
Did IN8bio beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.18 by $0.08.
How did IN8bio's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 550.0% from $-0.04.
Where can I find IN8bio's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-104144) and the 10-K periodic report (0001193125-26-104181) directly on SEC EDGAR. The filing index links above go to sec.gov.